SAVE the DATE
ROCK Society 2020 Annual Meeting
April 24 - 25, 2020
University of Alabama at Birmingham
Upcoming Stones Seminar
Obesity and Kidney Stone Conference
Hosted by the University of Alabama Center for Research on Obesity and Oxalate Kidney Stones (COOKS) NIDDK P20
July 11-12, 2019
Please join us in Birmingham, Ala., as we work to establish a broad based network of scientific expertise to define the relationship between obesity and kidney stone disease.
The NIDDK-funded P20 Developmental Center for Benign Urology Research at the University of Alabama (UAB) at Birmingham (PI: Dean Assimos) is hosting a seminar, "Obesity and kidney stone risk," on July 11-12 in Birmingham, AL. The focus of the UAB P20 grant is to elucidate mechanisms of action for the influence of obesity on endogenous oxalate synthesis and involves PhD scientists Ross Holmes, John Knight, and Tanecia Mitchell as well as urologist Kyle Wood. The group also works closely with Barbara Gower, PhD, of the UAB Nutrition Obesity Research Center (NORC). The seminar will start at noon on the 11th; sessions will run through the day on the 12th. Scheduled speakers include faculty from the UAB NORC, Dr. Marguerite Hatch of the University of Florida, and physician scientists from the UT Southwestern Mineral Metabolism group, Drs. Orson Moe, Khashayar Sakhaee, Naim Maalouf, and Margaret Pearle.
Program runs from Thursday, July 11th at 1:00 PM, through Friday, July 12th at 3:00 PM
Get more information on travel, accommodations, and to register.
Travel awards for early investigators and students may be available for this symposium. Contact Dean Assimos for more information or to apply, email: email@example.com
Request for Applications:
Primary Hyperoxaluria Type 3 Oxalosis & Hyperoxaluria Foundation (OHF)
Funding Amount: Maximum $200,000.00 for up to two years.
Indirect costs must be included in the maximum funding amount.
Deadline for applications: August 1, 2019
Award Notification: October 1, 2019
Of the known genetic causes of primary hyperoxaluria, PH type 3 is the most recently identified and now known to be caused by mutations in the HOGA1 gene. Although the causative gene is known, we still lack much basic information regarding this disease. Indeed, it is not entirely clear how mutations in this gene cause hyperoxaluria. It is not clear what the natural history is of this disorder or if there are treatment approaches that might be uniquely beneficial for PH3 over PH types 1 and 2.
To fill these gaps the OHF specifically seeks funding applications to study PH Type 3. Applications could be clinical, translational, or basic science in focus. Possible areas of study include, but are not limited to, the mechanism(s) of hyperoxaluria, novel treatment strategies and targets, novel bio markers, and new information regarding risk factors for stone formation or chronic kidney disease in PH type 3. Apply Today!
Upcoming AUA Program of Interest:
Location: AUA Headquarters, Linthicum, MD
The AUA and the Endourological Society present a new collaborative scientific symposium focused on interdisciplinary, innovative translational research in kidney stone disease. As medical science undergoes an exciting revolution with the widespread use of new methodologies, engineers and the allied fields are developing ground breaking advances to help move medical technology forward. The goal of this symposium is to bring together experts in kidney stone research, engineering, physics and other scientific fields to lay the ground work for further advancements in this niche area.
There will be four main focus areas at the symposium:
- Stone formation and biology
- Surgical technology to break stones
- Artificial intelligence and big data applications for kidney stone treatment
- How to advance and fund innovative research
Mark your calendars now! Registration opens in June.
AUA Guidelines Related to Stone Management